The Zhitong Finance App learned that Giants Biotech (02367) fell by more than 4%. As of press release, it was down 4.51% to HK$20.34, with a turnover of HK$52.3634 million.

According to the news, on November 12, MSCI announced the quarterly index adjustment results for November 2026. This adjustment will take effect after closing on November 30. Among them, 38 shares, including Giant Biotech, were excluded from the MSCI China Index. Also, according to CMB International's observations on beauty e-commerce, among key domestic companies, Giazi Biotech's growth rate clearly turned negative, down 7.0% year on year in October and 14.0% in September, mainly dragged down by Ke Mei and Taotian channels. Furthermore, in this year's Tmall beauty TOP20 list, Kefumei, which was on the list last year, dropped out of the top 20 this year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.